Farmacity: cambio de timón

Bilingual Version

Sebastián Miranda, actual gerente general de supermercados Día está preparando sus petates para sentarse al frente del sillón principal de Farmacity.

Con gran experiencia en el sector de retail, Miranda también formó parte de Eki Discount, en la función de gerente comercial.

Por el momento Mario Quintana seguirá al mando del mayor minorista de farmacia de la Argentina y se cree que Miranda podría asumir en febrero.

Hay que recordar asimismo que Guillermo Bustos, quien llevara adelante una exitosa gestión al frente de Farmacity por 15 años, se inició en Carrefour y llegó a ser el director general de Tía.

La marca Día -enfocada en precios bajos- formaba parte del grupo francés Carrefour, quien se desprendió de esta marca a fines de 2011.

Esta primicia de Pharmabiz dará sin dudas tela para cortar entre laboratorios y farmacias competidoras quienes diseñan estrategias para recortar progresivamente la rentabilidad de la principal cadena de farmacia del país.

_____________________________________________________________________________________________________________

English Version

Farmacity: changing tack

Tuesday January 22^nd 2012

Sebastián Miranda, current general manager of Día supermarkets is packing up his bags to sit on Farmacity’s main chair.

With great experience in the retail sector, Miranda was also part of Eki Discount, in the position of commercial manager.

In the meantime, Mario Quintana -the current CEO of Farmacity– will continue to lead the largest pharmaceutical retailer of the country and it is believed that Miranda could step up next February.

In addition, it is important to remember that Guillermo Bustos, who lead a successful administration heading up Farmacity for 15 years, began his career in Carrefour and got to the position of general director of Tía.

The brand Día –focused on low prices- was part of the French group Carrefour, who got rid of this brand by the end of 2011.

This scoop brought by Pharmabiz will undoubtedly give a lot to talk about between laboratories and competing pharmacies that design strategies to gradually cut back the profitability of the main pharmacy chain of the country.